Drug/Insect/Latex News

A cell protein known as LMAN1 plays a role in responses to house dust mite, opening potential avenues for new treatments for these and other allergies, according to a study published in Cell Reports.

Even though most patients who were evaluated for a drug allergy were recommended for more testing, nearly one-third of them did not complete additional evaluation, according to a letter published in Annals of Allergy, Asthma & Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in June.

Subcutaneous immunotherapy for house dust mite allergy may slightly protect patients against SARS-CoV-2 infection, especially after the dose-escalation phase, according to a letter published in Clinical and Translational Allergy.

Nearly half of patients with alpha-gal syndrome have had an anaphylactic reaction to health products that include alpha gal, according to a study presented at the DIA 2023 Annual Global Meeting in Boston.

The Allergen Disclosure in Non-Food Articles Act would amend the Food, Drug, and Cosmetic Act to require labels on drugs intended for human use to indicate if they include ingredients derived from the top nine food allergens or glutens.

Children with a history of allergy to COVID-19 vaccines or pre-existing conditions that put them at higher risk for a reaction safely tolerated testing and challenges, according to a letter published in Clinical and Translational Allergy.

Physicians should perform graded direct challenges when patients at low risk for a reaction report an antibiotic allergy, according to a review published in Annals of Allergy, Asthma & Immunology.

Patients with hematologic malignancies and penicillin or amoxicillin allergies passed challenges to these labels and received beta-lactam antibiotics, according to a study published in Antimicrobial Stewardship & Healthcare Epidemiology.

Patients with an adverse reaction to a COVID-19 vaccine can receive future doses, suggesting that their previous symptoms were not mediated by IgE, according to a letter published in Annals of Allergy, Asthma and Immunology.